Analysis of Impurities in Fine Chemical Octyl-dimethyl-4- aminobenzoate Using the Agilent 1290 Infinity LC and ZORBAX RRHT and RRHD 1.8 µm Columns
The combined benefits are demonstrated by a separation of impurities found in a sample of octyl-dimethyl-4-aminobenzoate.
Michael Woodman, Agilent Technologies, Inc.
The combined benefits are demonstrated by a separation of impurities found in a sample of octyl-dimethyl-4-aminobenzoate. The high pressure capability of the system allows the use of methanol, as well as acetonitrile, to explore the selectivity of the two solvents. At 1.5 mL/min, using a simple 2-min gradient and a 3.0 mm X 50 mm 1.8 µm column, the analysis time is only 3 min. The separation of the main components is shown in Figure 1.
Figure 1
The speed, resolution and flexibility of the system are further demonstrated by a separation of the sample using methanol or acetonitrile with low solvent consumption 2.1 mm id, 1.8 µm columns. The flow rate and gradient conditions are optimized for each solvent, to produce a gradient separation with maximum pressure of approximately 850 bar, a conservative setting for the 1200-bar capability of the Agilent 1290 Infinity LC. The separation of the main components, with the two organic solvents, is shown in Figure 2a (acetonitrile, top panel) and 2b (methanol, lower panel), where the chromatograms are zoomed to the region of peaks shown from approximately 1.2–2.5 min in Figure 1.
Figure 2
Configuration
- G4220A 1290 Infinity Binary Pump with Integrated Vacuum
Degasser
- G4226A 1290 Infinity Autosampler
- G1316C 1290 Infinity Thermostatted Column Compartment
- G4212A 1290 Infinity Diode Array Detector
Conclusions
The combined high flow and high pressure capability of the system allows one to use high efficiency columns, producing rapid separations with remarkable resolution while conserving solvent over the use of 4.6 mm id columns. Impurity detection, due to high detector sensitivity and stability, is estimated to be ? 0.01%.
Agilent Technologies, Inc.
2850 Centerville Road, Wilmington, DE 19808
tel. (800)227-9770; fax (302)633-8901
Website: www.agilent.com
Top-down characterization of engineered Bcl-xL proteoforms
October 11th 2024Top-down fragmentation enables rapid characterization of phosphorylated proteins without extensive sample preparation and digestion. In this study, electron capture dissociation (ECD) was used to fragment proteoforms of the cell death-related protein, Bcl-xL. Using these methods, 85–90% sequence coverage was achieved for Bcl-xL proteoforms, allowing for effective localization of phosphorylation within minutes.
Antibody peptide mapping using the new Agilent ExD cell
October 11th 2024Enhanced antibody analysis using electron capture dissociation (ECD) allows for precise glycan localization in low-abundance glycopeptides. This study compares the fragmentation of trastuzumab tryptic digests using ECD and collision-induced dissociation (CID). While CID generates abundant glycan HexNAc ions at 204 m/z, ECD preserves the labile glycan group, enabling accurate site localization.
Identification of Amino Acid Isomers Using Electron Capture Dissociation
October 11th 2024Electron capture dissociation produces distinct fragments of amino acid side chains, enabling the identification of isomeric amino acids such as leucine and isoleucine. This application note demonstrates the isomer identification workflow for peptides and intact proteins using the new Agilent ExD cell and ExDViewer software for fragment analysis.
Trends, Best Practices, and Analytical Challenges in Chemical Characterization of Medical Devices
October 7th 2024Chemical characterization of medical devices, including drug-device combination products, is crucial for ensuring regulatory compliance and patient safety by identifying and quantifying chemicals that may interact with the human body. This paper explores current trends, best practices, and regulatory developments in extractables and leachables (E&L) testing for medical devices.
